½ÃÀ庸°í¼­
»óǰÄÚµå
1463733

Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀå ¿¹Ãø(2030³â) : Áö¿ªº° ºÐ¼® - À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°

South & Central America Bariatric Surgeries Market Forecast to 2030 - Regional Analysis - by Type and End User (Hospitals and Ambulatory Surgical Centers)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 64 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀåÀº 2022³â¿¡ 2¾ï 8,251¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2030³â¿¡´Â 8¾ï 7,378¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2022-2030³âÀÇ CAGRÀº 15.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ±â¾÷ÀÇ Àü·«Àû ±¸»óÀÌ Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀåÀ» Áö¿ø

¼¼°è ·¹º§·Î ºñ¸¸ÀÇ À¯º´·üÀÌ °è¼Ó Áõ°¡Çϰí ÀÖÀ¸¸ç, ºñ¸¸ ¼ö¼ú ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´Ù¾çÇÑ ½ÃÀå ±â¾÷ÀÌ ºñ¸¸ ¼ö¼ú½Ã µµ¿òÀÌ µÇ°í, ¾çÈ£ÇÑ °á°ú¸¦ ÃÊ·¡Çϴ ÷´Ü Á¦Ç° °³¹ßÀ» À§ÇØ Á¦Ç°ÀÇ ¹ß¸Å ¹× Àü·«Àû Á¦ÈÞ¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù Á¦Ç°ÀÇ ¹ß¸Å, ÇÕº´, Àμö µî ´Ù¾çÇÑ µ¿ÇâÀÌ ÀÖ¾ú½À´Ï´Ù. ±× Áß ¸î °¡Áö¸¦ ¾Æ·¡¿¡ ¼Ò°³ÇÕ´Ï´Ù. :

  • 2021³â 6¿ù, ¿¡Æ¼ÄÜÀº »õ·Î¿î ÷´Ü ¾ç±Ø¼º ¿¡³ÊÁö ÀåºñÀÎ ENSEAL X1 Curved Jaw Tissue Sealer¸¦ Ãâ½ÃÇÏ¿© LigaSure Marylandº¸´Ù ´õ °­·ÂÇÑ ¹ÐºÀ°ú ´õ ¸¹Àº Á¶Á÷¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Á¦°øÇÏ¿© ½Ã¼ú È¿À²À» Çâ»ó½ÃÅ´. ÇÕ´Ï´Ù. ÀÌ Àåºñ´Â ´ëÀå, ºÎÀΰú, ºñ¸¸ ¼ö¼ú, ÈäºÎ ¼ö¼ú¿¡ »ç¿ëµË´Ï´Ù.
  • Áö³­ 11¿ù º¸½ºÅÏ »çÀ̾ðƼÇÈ ÄÚÆÛ·¹À̼Ç(Boston Scientific Corporation)Àº ¾ÆÆú·Î ¿£µµ¿Ü°ú(Apollo Endosurgery)¸¦ ¾à 6¾ï 1,500¸¸ ´Þ·¯¿¡ ÀμöÇß½À´Ï´Ù. Apollo EndosurgeryÀÇ Á¦Ç° Æ÷Æ®Æú¸®¿À¿¡´Â ¼ÒÈ­°ü Æó¼â ¹× °ü¸®¸¦ À§ÇÑ ³»½Ã°æ ¼ö¼ú(ELS) ½Ã¼ú¿¡ »ç¿ëµÇ´Â Àåºñ°¡ Æ÷ÇԵ˴ϴÙ.
  • 2021³â 9¿ù, ¿Ã¸²Çª½º´Â POWERSEAL·Î ¾Ë·ÁÁø »õ·Î¿î ÷´Ü ¾ç±Ø¼º ¼ö¼ú¿ë ¿¡³ÊÁö Á¦Ç°±ºÀÎ POWERSEAL 5mm Curved Jaw Tissue Sealer and Divider¸¦ ÀμöÇß½À´Ï´Ù. ÀÎü°øÇÐÀû ´Ù±â´É ¼³°è·Î ½Ã¼úÀÇ È¿À²¼ºÀ» ³ôÀ̰í ÀÏÁ¤ÇÑ ¹ÐºÀ ½Å·Ú¼ºÀ» Á¦°øÇÏ¿© °í±Þ ¾ç±Ø¼º ¼ö¼ú¿ë ¿¡³ÊÁö ÀåºñÀÇ ÀÇ·á ¼º´É¿¡ ´ëÇÑ ÃÖ°í ±âÁØÀ» ÃæÁ·ÇÏ´Â ÀÌÁß µ¿ÀÛ Àåºñ·Î ÀÏ¹Ý ¿Ü°ú, ºÎÀΰú, ´ëÀåÇ×¹® ¼ö¼ú, ºñ¸¸ ¼ö¼ú, ºñ´¢±â°ú, ÈäºÎ ¼ö¼ú, Ç÷°ü ¼ö¼ú µî ´Ù¾çÇÑ ¼ö¼ú¿¡ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù, ¼ö¸¹Àº ¼ö¼ú¿¡ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

µû¶ó¼­ Á¦Ç° Ãâ½Ã, °³¹ß ¹× Àü·«Àû Á¦ÈÞÀÇ ±ÞÁõÀº ÇâÈÄ ºñ¸¸ ¼ö¼ú Àåºñ ½ÃÀå¿¡ Å« ¼ºÀå ±âȸ¸¦ °¡Á®¿Ã °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀå °³¿ä

Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ Áß³²¹Ì·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀåÀº ÁÖ·Î °Ç°­°ú º¹Áö¿¡ °üÇÑ ÀǽÄÀÇ Çâ»ó¿¡ ÀÇÇÑ °ÍÀÔ´Ï´Ù.

Biomaterials Research Àú³Î¿¡ °ÔÀçµÈ ±â»ç¿¡ µû¸£¸é 2020³â ºê¶óÁúÀº ¼¼°è¿¡¼­ ´ç´¢º´ ȯÀÚ°¡ °¡Àå ¸¹Àº 10°³±¹ Áß 5À§¸¦ Â÷ÁöÇß½À´Ï´Ù. ±¹Á¦ÀûÀÎ Ã߻꿡 µû¸£¸é 2030³â±îÁö ºê¶óÁúÀÇ ´ç´¢º´ À¯º´·üÀº 6%¿¡¼­ 7.8%·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºñ¸¸Àº ´ç´¢º´ÀÇ ÁÖ¿ä À§Çè ¿ä¼ÒÀ̸ç, ºñ¸¸ ¼ö¼úÀÇ ½ÃÇàÀ¸·Î ÀÌ À§Çè ¿ä¼Ò¸¦ °ü¸®ÇÒ ¼ö ÀÖÀ¸¹Ç·Î ºê¶óÁúÀÇ ºñ¸¸ ¼ö¼ú ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ¿©·¯ ½ÃÀå ±â¾÷ÀÌ À¯±âÀû Àü·«À» äÅÃÇϰí ÀÖÀ¸¸ç, 2022³â 10¿ù ºê¶óÁú º¸°Ç ±ÔÁ¦±â°üÀÎ ANVISA´Â AllurionÀÌ À§ dz¼± ±â¼úÀΠŸ¿øÇü dz¼±À» ºê¶óÁú¿¡¼­ Ãâ½ÃÇÒ ¼ö ÀÖµµ·Ï ½ÂÀÎÇß½À´Ï´Ù. Ÿ¿øÇü dz¼±Àº ¼ö¼ú, ¸¶Ãë, ³»½Ã°æ °Ë»ç ¾øÀÌ À§Àå¿¡ »ðÀÔÇϰí Á¦°ÅÇÒ ¼ö ÀÖ½À´Ï´Ù.

Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀåÀÇ ¸ÅÃâ°ú 2030³â±îÁöÀÇ ¿¹Ãø(±Ý¾×)

Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀå ¼¼ºÐÈ­

Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀåÀº À¯Çü, ÃÖÁ¾»ç¿ëÀÚ, ±¹°¡·Î ¼¼ºÐÈ­µË´Ï´Ù.

À¯Çüº°·Î´Â Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀåÀº Á¶Àý °¡´ÉÇÑ À§¹êµå(AGB), ½½¸®ºêÀ§ ÀýÁ¦¼ú, À§ ¹ÙÀÌÆÐ½º, ½ÊÀÌÁöÀå ½ºÀ§Ä¡ ºÎÂø ´ãÃéÀüȯ¼ú(BPD-DS), ±âŸ·Î ºÐ·ùµË´Ï´Ù. 2022³â¿¡´Â ½½¸®ºêÀ§ ÀýÁ¦¼ú ½ÃÀå ºÎ¹®ÀÌ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚÀÇ °üÁ¡À¸·ÎºÎÅÍ Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀåÀº º´¿ø°ú ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ·Î 2ºÐµË´Ï´Ù. º´¿ø ºÎ¹®ÀÌ 2022³â¿¡ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±¹°¡º°·Î º¸¸é Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ ³²¹Ì·Î ±¸ºÐµË´Ï´Ù. ºê¶óÁúÀº 2022³â¿¡ Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.

Conmed Corp, Intuitive Surgical Inc, Medtronic Plc, Olympus Corp, Reshape Lifesciences Inc´Â Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀå¿¡¼­ »ç¾÷À» ¿î¿µÇϰí ÀÖ´Â ´ë±â¾÷ÀÇ ÀϺÎÀÔ´Ï´Ù.

¸ñÂ÷

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®
  • Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀå : ±¹°¡º°

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå Áß³²¹ÌÀÇ ºñ¸¸ ¼ö¼ú ½ÃÀå : ÁÖ¿ä »ê¾÷ ¿ªÇÐ

  • ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎ
    • ºñ¸¸ÀÇ À¯º´·ü Áõ°¡
    • Àúħ½À¼ö¼ú¿¡ ´ëÇÑ ¼ö¿äÀÇ Áõ°¡
  • ÁÖ¿ä ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ¾ö°ÝÇÑ ±ÔÁ¦ Á¤Ã¥°ú ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ì·ÁÀÇ Áõ°¡
  • ÁÖ¿ä ½ÃÀå ±âȸ
    • ½ÃÀå ±â¾÷¿¡ ÀÇÇÑ Àü·«Àû ±¸»ó
  • ÁÖ¿ä ½ÃÀå µ¿Çâ
    • ±â¼úÀÇ Áøº¸
  • ¿µÇ⠺м®

Á¦5Àå ºñ¸¸ ¼ö¼ú ½ÃÀå : Áß³²¹Ì ½ÃÀå ºÐ¼®

  • Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀå ÆÇ¸Å ½ÇÀû, 2022-2030³â

Á¦6Àå Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀå : 2030³â±îÁöÀÇ ¸ÅÃâ°ú ¿¹Ãø : À¯Çüº°

  • Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀå 2022³â¡¤2030³â À¯Çüº° ÆÇ¸Å°í Á¡À¯À²(%)
  • Á¶Àý °¡´ÉÇÑ À§¹êµå(AGB)
  • ½½¸®ºêÀ§ ÀýÁ¦¼ú
  • À§ ¹ÙÀÌÆÐ½º¼ú
  • BPD-DS(Biliopancreatic Diversion with Duodenal Switch)
  • ±âŸ

Á¦7Àå Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀå : 2030³â±îÁöÀÇ ¸ÅÃâ°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°

  • 2022³â ¹× 2030³â¿¡¼­ Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀå ÃÖÁ¾»ç¿ëÀÚº° ÆÇ¸Å°í Á¡À¯À²(%)
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ

Á¦8Àå Áß³²¹Ì ºñ¸¸ ¼ö¼ú ½ÃÀå - 2030³â±îÁöÀÇ ¸ÅÃâ°ú ¿¹Ãø - ±¹°¡º° ºÐ¼®

  • ºê¶óÁú
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ Áö¿ª

Á¦9Àå ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå - ¾÷°è »óȲ

  • ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå¿¡¼­ÀÇ ¼ºÀå Àü·«
  • À¯±âÀû ¼ºÀå Àü·«
  • ¹«±âÀû ¼ºÀå Àü·«

Á¦10Àå ±â¾÷ °³¿ä

  • Intuitive Surgical Inc
  • Conmed Corp
  • Medtronic Plc
  • Olympus Corp
  • Reshape Lifesciences Inc

Á¦11Àå ºÎ·Ï

KSA 24.04.26

The South & Central America bariatric surgeries market was valued at US$ 282.51 million in 2022 and is expected to reach US$ 873.78 million by 2030; it is estimated to grow at a CAGR of 15.2% from 2022 to 2030.

Strategic Initiatives by Market Players Fuels the South & Central America Bariatric Surgeries Market

There has been a constant increase in the prevalence of obesity on a global level that has increased the demand for bariatric surgery devices. Various market players are also focused on product launches or strategic collaborations for the development of advanced products that help during bariatric surgeries and provide positive outcomes. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years. A few of them are mentioned below:

  • In June 2021, Ethicon launched a new advanced bipolar energy device, the ENSEAL X1 Curved Jaw Tissue Sealer. It enhances procedural efficiency by providing stronger sealing and greater access to more tissue than LigaSure Maryland. The device is used for colorectal, gynaecological, and bariatric surgeries and thoracic procedures.
  • In November 2022, Boston Scientific Corporation acquired Apollo Endosurgery Inc. with a total value of approximately US$ 615 million, which indicated a cash price of US$ 10 per share. The Apollo Endosurgery product portfolio includes devices used during endoluminal surgery (ELS) procedures to close and manage gastrointestinal
  • In September 2021, Olympus acquired the new advanced bipolar surgical energy product range known as POWERSEAL. The POWERSEAL 5 mm Curved Jaw Tissue Sealer and Divider is a double-action device that meets the highest standards of medical performance for advanced bipolar surgical energy devices by delivering constant sealing reliability in an ergonomic and multifunctional design that promotes procedural efficiency. The POWERSEAL devices can be employed in numerous surgical procedures, including general, gynaecological, colorectal, bariatric, urological, thoracic, and vascular surgical procedures.

Thus, a surge in product launches, development, and strategic collaborations is likely to create considerable growth opportunities for the bariatric surgery devices market in the future.

South & Central America Bariatric Surgeries Market Overview

The South & Central America bariatric surgeries market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is primarily attributed increasing awareness regarding health and well-being.

According to an article published in Biomaterials Research, in 2020, Brazil is among the 10 countries in the world with the highest number of people with diabetes and was ranked 5th. By 2030, the prevalence of diabetes in the country is expected to increase from 6% to 7.8%, according to international estimates. Obesity is the major risk factor for diabetes, which is taken care of by performing bariatric surgeries, thereby driving the demand for bariatric surgery devices in Brazil.

Several market players are adopting organic strategies to stay competitive in the market. In October 2022, the Brazilian Health Regulatory Agency ANVISA approved Allurion to launch its gastric balloon technology-the Elipse Balloon-in Brazil. The Elipse Balloon can be placed in the stomach and removed without surgical procedure, anesthesia, or endoscopy.

South & Central America Bariatric Surgeries Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Bariatric Surgeries Market Segmentation

The South & Central America bariatric surgeries market is segmented into type, end user, and country.

Based on type, the South & Central America bariatric surgeries market is categorized adjustable gastric bands (AGB), sleeve gastrectomy, gastric bypass, biliopancreatic diversion with duodenal switch (bpd- ds), and others. The sleeve gastrectomy market segment held the largest share in 2022.

In terms of end user, the South & Central America bariatric surgeries market is bifurcated into hospitals and ambulatory surgical centers. The hospitals segment held a larger share in 2022.

Based on country, the South & Central America bariatric surgeries market is segmented Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bariatric surgeries market in 2022.

Conmed Corp, Intuitive Surgical Inc, Medtronic Plc, Olympus Corp, and Reshape Lifesciences Inc are some of the leading companies operating in the South & Central America bariatric surgeries market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 South & Central America Bariatric Surgeries Market, by Country (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Bariatric Surgeries Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Increasing Prevalence of Obesity
    • 4.1.2 Growing Demand for Minimally Invasive Surgeries
  • 4.2 Key Market Restraints:
    • 4.2.1 Stringent Regulatory Policies and Increase in Safety Concerns
  • 4.3 Key Market Opportunities:
    • 4.3.1 Strategic Initiatives by Market Players
  • 4.4 Key Market Trends:
    • 4.4.1 Technological Advancement
  • 4.5 Impact Analysis

5. Bariatric Surgeries Market - South & Central America Market Analysis

  • 5.1 South & Central America Bariatric Surgeries Market Revenue (US$ Million), 2022 - 2030

6. South & Central America Bariatric Surgeries Market - Revenue and Forecast to 2030 - by Type.

  • 6.1 Overview
  • 6.2 South & Central America Bariatric Surgeries Market Revenue Share, by Type 2022 & 2030 (%)
  • 6.3 Adjustable Gastric Bands (AGB)
    • 6.3.1 Overview
    • 6.3.2 Adjustable Gastric Bands (AGB): South & Central America Bariatric Surgeries Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Sleeve Gastrectomy
    • 6.4.1 Overview
    • 6.4.2 Sleeve Gastrectomy: South & Central America Bariatric Surgeries Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Gastric bypass
    • 6.5.1 Overview
    • 6.5.2 Gastric bypass: South & Central America Bariatric Surgeries Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Biliopancreatic Diversion with Duodenal Switch (BPD- DS)
    • 6.6.1 Overview
    • 6.6.2 Biliopancreatic Diversion with Duodenal Switch (BPD- DS): South & Central America Bariatric Surgeries Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: South & Central America Bariatric Surgeries Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Bariatric Surgeries Market - Revenue and Forecast to 2030 - by End User

  • 7.1 Overview
  • 7.2 South & Central America Bariatric Surgeries Market Revenue Share, by End User 2022 & 2030 (%)
  • 7.3 Hospitals
    • 7.3.1 Overview
    • 7.3.2 Hospitals: South & Central America Bariatric Surgeries Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Ambulatory Surgical Centers
    • 7.4.1 Overview
    • 7.4.2 Ambulatory Surgical Centers: South & Central America Bariatric Surgeries Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Bariatric Surgeries Market - Revenue and Forecast to 2030 - Country Analysis

  • 8.1 Overview
    • 8.1.1 South & Central America Bariatric Surgeries Market, by Country, 2022 & 2030 (%)
      • 8.1.1.1 Brazil: South & Central America Bariatric Surgeries Market
        • 8.1.1.1.1 Brazil: South & Central America Bariatric Surgeries Market- Revenue and Forecasts to 2030 (US$ Million)
        • 8.1.1.1.2 Brazil: South & Central America Bariatric Surgeries Market, by Type, 2020-2030 (US$ Million)
        • 8.1.1.1.3 Brazil: South & Central America Bariatric Surgeries Market, by End User, 2020-2030 (US$ Million)
      • 8.1.1.2 Argentina: South & Central America Bariatric Surgeries Market
        • 8.1.1.2.1 Argentina: South & Central America Bariatric Surgeries Market- Revenue and Forecasts to 2030 (US$ Million)
        • 8.1.1.2.2 Argentina: South & Central America Bariatric Surgeries Market, by Type, 2020-2030 (US$ Million)
        • 8.1.1.2.3 Argentina: South & Central America Bariatric Surgeries Market, by End User, 2020-2030 (US$ Million)
      • 8.1.1.3 Rest of South & Central America Bariatric Surgeries Market
        • 8.1.1.3.1 Rest of South & Central America Bariatric Surgeries Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.3.2 Rest of South & Central America Bariatric Surgeries Market, by Type, 2020-2030 (US$ Million)
        • 8.1.1.3.3 Rest of South & Central America Bariatric Surgeries Market, by End User, 2020-2030 (US$ Million)

9. Bariatric Surgery Devices Market-Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in Bariatric Surgery Devices Market
  • 9.3 Organic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Inorganic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Intuitive Surgical Inc
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Conmed Corp
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Medtronic Plc
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Olympus Corp
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Reshape Lifesciences Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments

11. Appendix

  • 11.1 About Us
  • 11.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦